“…Interestingly, CCG-III, another folded isomer, enhanced the iGluRs responses by the co-administration of L-Glu, despite the fact that CCG-III itself activated iGluRs with lesser potency than did L-Glu. 5,6 We found that the potentiation was attributed to inhibition of removal of L-Glu; that is, inhibition of glutamate transporters. At that time, studies on glutamate transporters trailed behind those of the receptors mainly because the transporters, unlike the receptors, received little attention as drug targets.…”